How to Use CBD Oil for Pain?

CBD oil offers the pain-relieving results of marijuana minus its psychoactive effects. It lets people benefit from the great uses of the cannabis compound CBD without the herb’s high and its side effects. CBD is a popular abbreviation of cannabidiol, which is an essential cannabis component. As per several experts and the findings of many […]

The post How to Use CBD Oil for Pain? appeared first on Latest Cannabis News Today – Headlines, Videos & Stocks.

Benefits of Cannabis Coconut Oil

If you are looking for a supertonic that can benefit skin conditions, chronic pain, and dental issues, reach for cannabis coconut oil. No kidding! Cannabis coconut oil is genuinely remarkable. Here’s a look into it and why it’s worth using! Cannabis coconut oil is anti-everything Coconut is a known superfood for many reasons. Full of […]

The post Benefits of Cannabis Coconut Oil appeared first on Latest Cannabis News Today – Headlines, Videos & Stocks.

Friday, February 14, 2020 Headlines | Marijuana Today Daily News

Marijuana Today Daily Headlines
Friday, February 14, 2020 | Curated by host Shea Gunther

// Los Angeles County expunges 66,000 marijuana convictions in a day (Leafly)

// Aurora Cannabis reports steep loss, production drop, and higher costs (Marijuana Business Daily)

// California unions ask state’s Democrats to shut out major cannabis trade group (Marijuana Business Daily)


These headlines are brought to you by Atlantic Farms, a Maine-based multistate cannabis business with operations in Maine and Massachusetts. Atlantic Farms is looking for people to help it grow and evolve as investors. Open up TheAtlanticFarms.com for more on the company and email info@theatlanticfarms.com to learn about investment opportunities.


// Baker’s anti-stoned driving bill is dead- but marijuana cafes and employee protections move ahead in Legislature (Boston Globe)

// Scientists Find Aluminum Cans Suck Cannabinoids Out of Infused Beverages (Merry Jane)

// Taxes a big factor behind the financial woes of California marijuana companies (Marijuana Business Daily)

// Scotland Opens First Medical Cannabis Clinic to Treat Chronic Pain (Merry Jane)

// A Psychedelics Company Is About to List on a Public Stock Exchange (Merry Jane)

// California ‘vape art’ exhibit flashes bright light on waste issue (Reuters)

// Las Vegas dispensary offers free joints to Nevada primary voters (Leafly)


Check out our other projects:
Marijuana Today— Our flagship title, a weekly podcast examining the world of marijuana business and activism with some of the smartest people in the industry and movement.
Marijuana Media Connect— A service that connects industry insiders in the legal marijuana industry with journalists, bloggers, and writers in need of expert sources for their stories.

Love these headlines? Love our podcast? Support our work with a financial contribution and become a patron.

Photo: Daniel Gillaspia/Flickr

Monday, April 27, 2020 Headlines | Marijuana Today Daily News

Marijuana Today Daily Headlines
Monday, April 27, 2020 | Curated by host Shea Gunther

// Top New York Lawmaker Wants To Pass Marijuana Legalization This Year Despite Coronavirus (Marijuana Moment)

// Marijuana Seems To Reduce Opioid Use Among Chronic Pain Patients, Meta-Study Finds (Marijuana Moment)

// Australia moves toward over-the-counter CBD sales (Marijuana Business Daily)


These headlines are brought to you by MJToday Media, publishers of this podcast as well as our weekly show Marijuana Today and the most-excellent Green Rush Podcast. And check out our new show Weed Wonks!


// Massachusetts marijuana store seeks medical license amid coronavirus shutdown (Mass Live)

// Ohio allowing phone orders, curbside pickup at medical cannabis stores (Marijuana Business Daily)

// State-By-State COVID-19 Announcements Impacting Marijuana Businesses (JD Supra)

// Massachusetts marijuana: In lawsuit over 2-year moratorium allowing only economic empowerment applicants to open, Appeals Court sides with Cambridge (Mass Live)

// Cannabis Has Become a Major Threat to Alcohol (Real Money)

// Arkansas medical marijuana consumers are buying in Oklahoma (Marijuana Business Daily)

// 1,700 soldiers in Alabama were drug tested a day after 4/20, but the Army says it’s ‘just a coincidence’ (Business Insider)


Check out our other projects:Marijuana Today— Our flagship title, a weekly podcast examining the world of marijuana business and activism with some of the smartest people in the industry and movement. • Marijuana Media Connect— A service that connects industry insiders in the legal marijuana industry with journalists, bloggers, and writers in need of expert sources for their stories.

Love these headlines? Love our podcast? Support our work with a financial contribution and become a patron.

Photo: Don Goofy/Flickr

When Your Partner Doesn’t Smoke…

For a true cannabis connoisseur, almost nothing sounds better than having a loving partner who you can share your most favorite thing with. Aside from always having a go-to person for a smoke sesh, the two of you get to compare notes about your favorite strains, geek out over new infused products and never have to worry about the other person judging you for doing something you enjoy. But, sometimes it doesn’t always work out that way. The way life works out, you may find yourself involved with someone who is anywhere from casually uninterested in cannabis to deeply critical about its use.

Kristen Bell recently made headlines when she admitted that she regularly smokes in front of her husband, Dax Shepard, who prefers not to partake for personal reasons. Luckily for the two of them, it’s a non-issue but for other couples, it can definitely create some friction unless you have some tips for keeping communication around it open and honest. It can be more than a bummer when your special person is weird or judgmental about smoking cannabis or eating edibles — it can actually be a deal breaker.

Before it gets that far, though, there are some things you can do to ease any potential tension. Educating your partner about cannabis is one of the most important things you can do. So many people misunderstand how useful cannabis can be for so many different people for many different reasons. Some people use it to help manage their pain, depression or anxiety while others incorporate it into their yoga practice, wellness routines and diets. Still, there are other people who just like chilling out, being social and enjoying a mental break. All reasons for use are valid and you should feel comfortable expressing where you fall on that spectrum.

You can also set some healthy boundaries that the both of you can work on together. For example, if smoke bothers your partner, you can agree not to smoke directly in front of them and use a vape or enjoy edibles instead. If their shady comments and subtle eyerolls whenever you pull out your paraphernalia for the third time that day get under your skin, talk to them about toning it down. You can also encourage them to do something that helps them unwind and chill out as well. Maybe they can stretch or meditate for 15 minutes while you smoke. Perhaps they can pour themselves a glass of wine and sip at their own leisure. Giving them something to do or an activity to keep them from getting bored while you smoke can help them from feeling like smoking takes away from your time together.

Still, with your best efforts, differences in lifestyle can be too much to handle for some relationships. It’s up to you whether or not you feel like breaking up over your partner’s attitude towards cannabis is worth it or not. On the surface it may seem like it’s just about cannabis but the real issue is whether or not your partner accepts you and your lifestyle as is. It’d be the same if you were vegan, agnostic or into longboarding — if your person can’t respect how you choose to live your life and makes you feel bad about it whether it’s intentional or not, then it’s probably best to part ways.

It’s okay if you have a partner that prefers not to use cannabis but just make sure that they are open to you being yourself, want you to feel comfortable doing something you enjoy and are willing to compromise if necessary.

TELL US, does your partner smoke cannabis?

The post When Your Partner Doesn’t Smoke… appeared first on Cannabis Now.

Monday, April 27, 2020 Headlines | Marijuana Today Daily News

Marijuana Today Daily Headlines
Monday, April 27, 2020 | Curated by host Shea Gunther

// Top New York Lawmaker Wants To Pass Marijuana Legalization This Year Despite Coronavirus (Marijuana Moment)

// Marijuana Seems To Reduce Opioid Use Among Chronic Pain Patients, Meta-Study Finds (Marijuana Moment)

// Australia moves toward over-the-counter CBD sales (Marijuana Business Daily)


These headlines are brought to you by MJToday Media, publishers of this podcast as well as our weekly show Marijuana Today and the most-excellent Green Rush Podcast. And check out our new show Weed Wonks!


// Massachusetts marijuana store seeks medical license amid coronavirus shutdown (Mass Live)

// Ohio allowing phone orders, curbside pickup at medical cannabis stores (Marijuana Business Daily)

// State-By-State COVID-19 Announcements Impacting Marijuana Businesses (JD Supra)

// Massachusetts marijuana: In lawsuit over 2-year moratorium allowing only economic empowerment applicants to open, Appeals Court sides with Cambridge (Mass Live)

// Cannabis Has Become a Major Threat to Alcohol (Real Money)

// Arkansas medical marijuana consumers are buying in Oklahoma (Marijuana Business Daily)

// 1,700 soldiers in Alabama were drug tested a day after 4/20, but the Army says it’s ‘just a coincidence’ (Business Insider)


Check out our other projects:Marijuana Today— Our flagship title, a weekly podcast examining the world of marijuana business and activism with some of the smartest people in the industry and movement. • Marijuana Media Connect— A service that connects industry insiders in the legal marijuana industry with journalists, bloggers, and writers in need of expert sources for their stories.

Love these headlines? Love our podcast? Support our work with a financial contribution and become a patron.

Photo: Don Goofy/Flickr

Cannabis And the Fight Against Multiple Sclerosis

Dealing with the physical and neurological effects of multiple sclerosis can be quite harrowing, new research shows how MS sufferers often turn to cannabis for relief.

While research is always ongoing, much has already been written about cannabis as an aid in helping with sleeping issues, depression, ADD, as having possibly potent anti-tumor properties, the ability to help regulate blood pressure, and as an immunological aid due to its anti-bacterial, anti-fungal, and anti-viral properties. The list goes on as far as research already done or ongoing that points to CBD (and cannabinoids in general) as being extremely useful in treating different medical ailments.

The idea of cannabis being useful for those suffering from multiple sclerosis is not new. There have been studies done on this subject over the years, and a growing body of medical research to support the theory.

Use the sign-up form to subscribe to the Medical Cannabis Weekly Newsletter

What is Multiple Sclerosis?

Multiple sclerosis (MS) is a central nervous system disease where the patient’s own immune system attacks the myelin that coats their nerve cells. The name of a disease that does this is a demyelinating disease. Myelin is important because it forms a cover over the nerve cells that allows for electrical impulses to efficiently transfer between nerve cells.

Damage to this myelin therefore can cause all kinds of transmission problems where impulses are slowed down, or not getting through correctly, or at all. This damage to the nerve cells causes different symptoms like tingling sensations, burning sensations, chronic pain, numbness, issues with balance and coordination, problems with bladder control, vision issues (often blindness in one eye), and fatigue.

The Medical Cannabis Weekly Newsletter

Where and how exactly multiple sclerosis comes about is still very much a mystery. As of yet there is no cure for multiple sclerosis and those that suffer from it are left to find the best ways to manage their symptoms. MS is way more commonly found in women, and generally comes on when a person is between the ages of 20-40 years old. About 2.5 million people suffer from it globally, some of whom experience what is called ‘relapsing remitting MS’ which is when a person’s symptoms come and go over time, essentially causing symptom relapses.

Because multiple sclerosis is a disease where the body is attacking itself, and damaging itself, it is known as an autoimmune disease. The cause for these diseases is unknown, but they all share the commonalities of a mis-functioning immune system that causes damage to the body. Other examples of autoimmune diseases are celiac disease, rheumatoid arthritis, Grave’s disease, and type 1 diabetes, to name just a few.

Older Research

The idea of using cannabis for MS is not new at all. In fact, a 2004 randomized, double-blind, placebo controlled study, was done to investigate just that. The investigators used a cannabis based medicinal extract (CBME) to test if it produced any benefit to multiple sclerosis sufferers over a placebo. Participants included 160 patients who all had substantial issues with spasticity, tremors, pain, bladder control issues, and spasms.

The results were interesting and showed outcomes through a Visual Analogue Scale (measures the frequency and intensity of a symptom), as well as looking at the patient’s level of fatigue, disability, their mood, cognitive abilities, and how they slept. Following the use of the cannabis extract, there was a reduction in primary symptom score from an average of 74.36 to an average of 48.89.

With the placebo it went down as well from 74.31 to 54.79. While the placebo group also did show a reduction in symptoms, the cannabis extract group showed a greater amount.

New Research

Earlier this month, a study was published called Cannabis use in people with multiple sclerosis and spasticity: A cross-sectional analysis. In this study, investigators took a look at cannabis use among people with multiple sclerosis who have spasticity issues. The study was done using self-reporting by patients. Several different key points of information are interesting when looking at this particular group of people. The study found the following:

Is CBD a Viable Treatment for Muscle Pain?

  • 36% use cannabis regularly
  • 54% have used cannabis in general
  • 58% of those who use cannabis, use it daily
  • 79% reported cannabis as being useful for helping with spasticity
  • 26% use prescribed cannabis
  • 85% of participants said cannabis was helpful with pain
  • 55% used topical cannabis applications, 52% reported administering with edibles
  • 26% use cannabis along with prescribed medications to deal with spasticity
  • 79% of those who use cannabis use multiple ways to administer it

Self-reporting studies like this are often interesting because they show what people with issues will naturally gravitate to. When people are sick, they generally go for the best option to feel better, and will stick with this, even if given other medical solutions.

It’s also interesting to see how they use cannabis, and how they see it effecting their symptoms. Self-reporting isn’t always the best way to gain information, and has its own pitfalls, but it can often show a pattern of behavior, and in this case it shows a pattern of MS sufferers with spasticity issues choosing to use cannabis to help with their symptoms.

Safety of Cannabis Use for Multiple Sclerosis

One of the questions that tends to come up when looking at cannabis use and multiple sclerosis is the safety of it. This question, of course, is prevalent when looking at any kind of treatment, but in this particular case, since cannabis has a certain reputation due to cannabinoid THC, the question does come up. In the first study I mentioned, which investigated using a CBME against a placebo, it was noted by the investigators that “There were no significant adverse effects on cognition or mood and intoxication was generally mild.”

This was investigated elsewhere as well. In 2018, investigators published a study which looked at the efficacy and tolerability of cannabis for multiple sclerosis patients. The idea was to see not just how well it worked for symptom maintenance, but how it effected the patient taking it. This study also used a randomized, double blind, placebo-controlled setup. The symptoms they were interested in most were pain, spasticity, and bladder function.

The results showed significant findings for cannabinoids producing relief for all three symptoms. While there were no severe adverse effects noted, when it came to tolerability, cannabinoids showed a possibly higher risk. Overall the study investigators concluded that cannabinoids do offer a certain efficacy, and are safe to use.

Into the Future

While firm answers might not be possible just yet, research has been promising and offers a glimmer of light to those suffering from multiple sclerosis. CBD, and cannabis in general, still hold quite a bit of mystery in terms of what they’re actually capable of, but those who use it already to help with their MS spasticity and pain issues seem to choose it whether their doctor prescribes it or not. And that sure says something.

Here at CBDtesters, we are happy to keep you updated on all the recent CBD, cannabinoid, and cannabis news. Check back often to keep yourself in the loop and make sure to subscribe to the Medical Cannabis Weekly Newsletter.

The post Cannabis And the Fight Against Multiple Sclerosis appeared first on CBD Testers.

Friday, February 14, 2020 Headlines | Marijuana Today Daily News

Marijuana Today Daily Headlines
Friday, February 14, 2020 | Curated by host Shea Gunther

// Los Angeles County expunges 66,000 marijuana convictions in a day (Leafly)

// Aurora Cannabis reports steep loss, production drop, and higher costs (Marijuana Business Daily)

// California unions ask state’s Democrats to shut out major cannabis trade group (Marijuana Business Daily)


These headlines are brought to you by Atlantic Farms, a Maine-based multistate cannabis business with operations in Maine and Massachusetts. Atlantic Farms is looking for people to help it grow and evolve as investors. Open up TheAtlanticFarms.com for more on the company and email info@theatlanticfarms.com to learn about investment opportunities.


// Baker’s anti-stoned driving bill is dead- but marijuana cafes and employee protections move ahead in Legislature (Boston Globe)

// Scientists Find Aluminum Cans Suck Cannabinoids Out of Infused Beverages (Merry Jane)

// Taxes a big factor behind the financial woes of California marijuana companies (Marijuana Business Daily)

// Scotland Opens First Medical Cannabis Clinic to Treat Chronic Pain (Merry Jane)

// A Psychedelics Company Is About to List on a Public Stock Exchange (Merry Jane)

// California ‘vape art’ exhibit flashes bright light on waste issue (Reuters)

// Las Vegas dispensary offers free joints to Nevada primary voters (Leafly)


Check out our other projects:
Marijuana Today— Our flagship title, a weekly podcast examining the world of marijuana business and activism with some of the smartest people in the industry and movement.
Marijuana Media Connect— A service that connects industry insiders in the legal marijuana industry with journalists, bloggers, and writers in need of expert sources for their stories.

Love these headlines? Love our podcast? Support our work with a financial contribution and become a patron.

Photo: Daniel Gillaspia/Flickr

Newest Cannabinoid Powerhouse – CBC – What Can It Do for You?

The ever-increasing cannabinoid family has new members coming in every day, and there’s reason to be excited as new research comes out about CBC.

In the last couple of years, CBD (cannabidiol) – a cannabis cannabinoid, has risen to prominence as an effective treatment for many suffering from medical issues like insomnia, anxiety, pain, depression, seizures, high blood sugars, pathogenic diseases, ADHD etc., and a possible answer to many other issues that still require more research like: different forms of cancer, neurodegenerative diseases, and even prion diseases. It seems like every day a new breakthrough is coming out about the use of CBD as a treatment.

It’s easy to forget that CBD, along with THC (Tetrahydrocannabinol) – the main cannabinoid of cannabis plants – are just two of the possibly hundreds of cannabinoids that are present in cannabis plants. In fact, by now, well over 100 cannabinoids have been identified, and each one – though sometimes only appearing in extremely small concentrations – has its own medicinal benefits. One of these lesser known cannabinoids that is starting to make it into the mainstream is CBC, or Cannabichromene.

Click here or use the sign up form below to subscribe to the Medical Cannabis Weekly Newsletter.

What is CBC?

Cannabichromene, which also goes by the names cannabichrome, pentylcannabichromene, cannabinochromene, and cannanbichromene is a phytocannabinoid that is structurally similar to other cannabinoids like THC, CBD and CBN, and the second most prevalent cannabinoid in cannabis.

Much like other cannabinoids, CBC does not actually start out as CBC, but rather as cannabichromenic acid, and is produced over time through decarboxylation. CBC is non-psychoactive, and interacts with the endocannabinoid system differently than both THC and CBD in that it only poorly binds to the CB1 and CB2 receptors in the brain.

In 2019, a study was done looking into the often misunderstood mechanisms of action of CBC, which found that CBC acts as a selective CB2 receptor agonist. As of yet it has not undergone scheduling by the Convention on Psychotropic Substances meaning it is legal to use as of now.

What does the research say about CBC?

The isolation of new cannabinoids means all new
avenues of medical research to go down. The studies on CBC, in fact, go back as
far as a 1981 study that tested the anti-inflammatory, antibacterial, and
antifungal properties of CBC in rats. According to the research, CBC showed anti-inflammatory
effects superior to phenylbutazone,
an NSAID anti-inflammatory/pain medication. It also showed to be a strong antibacterial
agent and a mild to moderate antifungal.

Then, in a 2006, study into the anti-tumor effects of cannabidiol, cannabigerol, cannabichromene, cannabidiol acid and THC acid, it was found that while CBD had a more expected effect on the inhibition of certain tumor growth in rats, the other cannabinoids tested, including CBC, did as well, leading investigators to point in the direction of further testing of cannabinoids for cancer treatment.

$2 Million Going To Cannabis Cancer Research Led By Professor Mechoulam

In 2010 there was a study investigating how CBD and CBC effect activity of the descending pathway of antinociception in anesthetized rats. It was found that both cannabinoids produce an antinociceptive response by interacting with various targets involved in pain control. A less complicated way of saying this is that both CBD and CBC were found to help alleviate pain caused by nerve damage by the ability to block the detection of pain by sensory neuron cells.

It was looked at again in 2012 as an inhibitor of
inflammation induced hyper motility in rats. The investigators were looking at
CBC as a way to control, or inhibit, the overactive digestive tracts in rats
that was caused as a result of inflammation. The results showed a positive correlation between CBC and the normalization of
intestinal motility.

In the 2013 study, The effect of cannabichromene on adult neural stem/progenitor cells, three different phytocannabinoids were looked at in reference to adult neural stem progenitor cells in rats. These cells are similar to stem cells, but more specified, and play a large role in brain function and overall pathology, making them very important. CBC was found to have a positive effect when looking at the viability of adult neural stem progenitor cells in vitro, indicating neural protective qualities.

An interesting systematic review from 2017 investigated the use of cannabinoids including CBC for the treatment of several different pathogenic diseases. The conclusion was important in that though it showed the use of cannabinoids and the elicitation of the endocannabinoid system to be useful in treating many issues, it also pointed to the idea that simply making the assumption that cannabinoids can help with all issues related to a problem, is quite insufficient.

‘This review was able to point to incidences in research where the application of cannabinoids and the elicitation of the endocannabinoid system was not beneficial, and possibly harmful. While this does not in any way undo, or take away from, the possible positive benefits, it does act as a reminder that it’s important to do thorough investigations that do, indeed, look at everything, and to remember that medications – whether plant-based or pharmaceutical – are often specific to a particular problem, and often times cannot be generalized past that.

CBC
shows similar properties to other cannabinoids in its anti-inflammatory, pain
management, neuroprotectant, pathogenic disease fighting, anti-tumor, and
stomach settling properties. Much like CBD and THC, the research into this
compound is ongoing, with new applications coming out all the time. CBC has
been shown in studies to both work alone as a standalone treatment, and in
conjunction with other cannabinoids.

Cannabichromene and the Entourage Effect

Cannabinoids effect us therapeutically by interacting with the CB receptors in our bodies.

While CBD, and cannabis in general, have risen to mainstream medicine, they are different than standard pharmaceuticals because they fall into the category of plant-based medicine. When dealing with plant-based medicine it is often preferable to take just one part of a plant – for example, a cannabinoid like CBC – isolate it, and magnify it for its specific medicinal properties.

This can often be beneficial when a particular property of a plant has been found to treat a precise ailment. Sometimes that’s the best answer. Sometimes it’s not. When dealing with plant-based medicine, the entourage effect can be a powerful force. When looking up the entourage effect online these days, you’re likely to only see articles about cannabis, when in reality this idea is relevant to all plant medicine.

Plants are complicated structures made up of different substances. These substances can provide benefit on their own, or combine with other substances within to create an even more powerful response, we call this the entourage effect, but what it really is, is a full plant effect. Instead of focusing on one isolated part of the plant, it focuses on the combination of parts and the added benefit that these combinations can bring.

When dealing with cannabinoids like CBC, CBD, CBN, THC, etc., the idea of what they can do in concert is often more appealing than what they can accomplish in isolated form. In this 2019 systematic review, researchers took a look at years of research into cannabinoid isolation versus a cannabinoid entourage effect, and the many different applications of both.

They found when reviewing this research that often times the entourage effect far exceeds the effects of a single compound. In this review are examples of cannabis applications for microbial diseases, cancer treatments, anti-inflammatory treatments, anticonvulsant properties, and so on.

CBC Products

CBC
has yet to gain the overall popularity of THC or CBD. As medical research
continues to uncover useful benefits, more products and flowers are sure to
make it to the marketplace. As of right now, CBC can be found in hemp capsules
from different retailers, as an isolate, in oils, and in hemp flowers.

One of
the more well-known high-CBC flower strains is Three Kings: a sativa dominant
hybrid mixing Headband, OG Kush, and Sour Diesel. It has bright green flowers
with tons of trichomes, and an earthy taste of pine and citrus when smoked or
vaped.

Be sure to search for the newest CBC products on the market. We’ll be sure to hook you up with the best new products as they emerge, while keeping you updated on all groundbreaking CBC news.

For more stories like this one, subscribe to the Medical Cannabis Weekly Newsletter.

The post Newest Cannabinoid Powerhouse – CBC – What Can It Do for You? appeared first on CBD Testers.

Migraines and our need for cannabinoids

We recently explored different ways that diet can cause and prevent migraines. A debilitating neurological condition resulting in unbearable pounding headaches that come with a variety of personalities. Some can be accompanied by aura or symptoms such as nausea. Stats Canada claimed 8.3% of Canadians experience migraines, with females suffering three times more often than […]

The post Migraines and our need for cannabinoids appeared first on Cannabis News | Lifestyle Tips | Expert Opinions | Stocks.